Clinical Trial Update: Effect of Sodium-glucose Cotransporter-2 Inhibitors (SGLT-2i) on Proteinuria in Nephrotic Children Older Than 10 Years [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether SGLT-2 inhibitors reduce proteinuria in children over 10 years with nephrotic syndrome; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome in Children

Drugs mentioned

• SGLT-2 inhibitors

Snippet

Sponsor: Mansoura University | Conditions: Nephrotic Syndrome in Children | Phase 4 | Status: RECRUITING